NCT02727868View on ClinicalTrials.gov

Assessment of the Mutation of Pig-A Gene as Biomarker of Genotoxic Exposure in Humans

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 3, 2016

Primary Completion Date

June 2, 2017

Study Completion Date

June 2, 2017

Conditions
Patient With Breast Cancer
Interventions
GENETIC

blood samples

Trial Locations (1)

13354

Assistance Publique Hôpitaux de Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT02727868 - Assessment of the Mutation of Pig-A Gene as Biomarker of Genotoxic Exposure in Humans | Biotech Hunter | Biotech Hunter